These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25817215)

  • 41. Nanodiamonds and silicon quantum dots: ultrastable and biocompatible luminescent nanoprobes for long-term bioimaging.
    Montalti M; Cantelli A; Battistelli G
    Chem Soc Rev; 2015 Jul; 44(14):4853-921. PubMed ID: 26051500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.
    Li W; Saji S; Sato F; Noda M; Toi M
    Int J Biol Markers; 2013 Jun; 28(2):117-30. PubMed ID: 23787494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design strategy for a near-infrared fluorescence probe for matrix metalloproteinase utilizing highly cell permeable boron dipyrromethene.
    Myochin T; Hanaoka K; Komatsu T; Terai T; Nagano T
    J Am Chem Soc; 2012 Aug; 134(33):13730-7. PubMed ID: 22830429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantum dots based molecular beacons for in vitro and in vivo detection of MMP-2 on tumor.
    Li X; Deng D; Xue J; Qu L; Achilefu S; Gu Y
    Biosens Bioelectron; 2014 Nov; 61():512-8. PubMed ID: 24951921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The role of matrix metalloproteinases in the pathogenesis of diabetes mellitus and progression of diabetes retinopathy].
    Naduk-Kik J; Hrabec E
    Postepy Hig Med Dosw (Online); 2008 Sep; 62():442-50. PubMed ID: 18772849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
    Liu J; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanoprobes for two-photon excitation time-resolved imaging of living animals: In situ analysis of tumor-targeting dynamics of nanocarriers.
    Yang W; Fu LM; Wen X; Liu Y; Tian Y; Liu YC; Han RC; Gao ZY; Wang TE; Sha YL; Jiang YQ; Wang Y; Zhang JP
    Biomaterials; 2016 Sep; 100():152-61. PubMed ID: 27258485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
    Karagiannis ED; Popel AS
    J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymeric AIE-based nanoprobes for biomedical applications: recent advances and perspectives.
    Zhang X; Wang K; Liu M; Zhang X; Tao L; Chen Y; Wei Y
    Nanoscale; 2015 Jul; 7(27):11486-508. PubMed ID: 26010238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biology of metalloproteinases.
    Amălinei C; Căruntu ID; Bălan RA
    Rom J Morphol Embryol; 2007; 48(4):323-34. PubMed ID: 18060181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emerging ultrasmall luminescent nanoprobes for
    Li S; Wei J; Yao Q; Song X; Xie J; Yang H
    Chem Soc Rev; 2023 Mar; 52(5):1672-1696. PubMed ID: 36779305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics.
    Rodríguez D; Morrison CJ; Overall CM
    Biochim Biophys Acta; 2010 Jan; 1803(1):39-54. PubMed ID: 19800373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells.
    Haage A; Schneider IC
    FASEB J; 2014 Aug; 28(8):3589-99. PubMed ID: 24784579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Matrix metalloproteinases and the thyroid.
    Kraiem Z; Korem S
    Thyroid; 2000 Dec; 10(12):1061-9. PubMed ID: 11201850
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic significance of matrix metalloproteinase expression in colorectal carcinomas.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2000; 14(5):659-66. PubMed ID: 11212843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluorescent activatable gadofullerene nanoprobes as NIR-MR dual-modal in vivo imaging contrast agent.
    Li C; Huang H; Cui R; Li J; Guo X; Yao H; Liu B; Xu B; Li Y; Liu S; Dong J; Xing G; Sun B
    Colloids Surf B Biointerfaces; 2018 Nov; 171():159-166. PubMed ID: 30029098
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metalloproteinases: A parade of functions in matrix biology and an outlook for the future.
    Apte SS; Parks WC
    Matrix Biol; 2015; 44-46():1-6. PubMed ID: 25916966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Facile Synthesis of Gadolinium Chelate-Conjugated Polymer Nanoparticles for Fluorescence/Magnetic Resonance Dual-Modal Imaging.
    Pan Y; Chen W; Yang J; Zheng J; Yang M; Yi C
    Anal Chem; 2018 Feb; 90(3):1992-2000. PubMed ID: 29293314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
    Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Matrix Metalloproteinases in Non-Neoplastic Disorders.
    Tokito A; Jougasaki M
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.